e-Drug3D 731 |
AZELAIC ACID
|
cas 123-99-9 |
CLASS DERMATOLOGICALS |
ROUTE (list) TOPICAL |
ATC code |
PK parameters F 4 PERCENT Solubility POORLY SOLUBLE IN WATER |
Target TARGET DIAMINOPIMELATE DECARBOXYLASE PDB Ligand code = AZ1 (link to the list of PDB complexes) Download experimental 3D coordinates of AZ1 with added hydrogens |
DrugCentral 3-oxo-5-alpha-steroid 4-dehydrogenase 2 UNIPROT P31213 SRD5A2 |
Download SDF file | nonanedioic acid Formula: Calculated chemical properties: MW 186.20 NB_atoms 13 XLogP -0.78 PSA 71.139 NB_HD 0 NB_HA 4 fsp3 0.78 Lipinski(0=no;1=yes) 1 |
FDA NDA 020428 (label) INN (AZELAIC ACID) AZELEX (ALMIRALL) APPROVAL= AP YEAR= 1995 NDA 021470 (label) INN (AZELAIC ACID) FINACEA (LEO PHARMA AS) APPROVAL= AP YEAR= 2002 NDA 207071 (label) INN (AZELAIC ACID) FINACEA (LEO PHARMA AS) APPROVAL= AP YEAR= 2015 NDA 204637 (pdf not found) INN (AZELAIC ACID) AZELAIC ACID (GLENMARK SPECLT) APPROVAL= AP YEAR= 2018 NDA 208011 (pdf not found) INN (AZELAIC ACID) AZELAIC ACID (ACTAVIS LABS UT INC) APPROVAL= AP YEAR= 2018 NDA 208724 (pdf not found) INN (AZELAIC ACID) AZELAIC ACID (ENCUBE) APPROVAL= AP YEAR= 2018 NDA 210549 (pdf not found) INN (AZELAIC ACID) AZELAIC ACID (TARO) APPROVAL= AP YEAR= 2019 NDA 210928 (pdf not found) INN (AZELAIC ACID) AZELAIC ACID (TEVA PHARMS USA) APPROVAL= AP YEAR= 2020 DISCONTINUED NDA 212581 (pdf not found) INN (AZELAIC ACID) AZELAIC ACID (TARO PHARM INDS LTD) APPROVAL= TA YEAR= 2021 |
Other links: |